Answers are grounded in this paper and cite their sources.
An 'on-demand' drug release and ROS-responsive nanoparticle was prepared by chemically conjugating hydrophobic α-tocopheryl succinate to hydrophilic poly(ethylene glycol) via a thioketal linker. This nanoparticle encapsulated with doxorubicin and α-tocopheryl succinate exhibited remarkable efficiency in reversing multidrug resistance both in vitro and in vivo.
No takes yet. Share an insight, caveat, or question.
Lv et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: